Biotech Values

[pcrutch]

Actually the CRL is much worse because of the following paragraph that HALO gave. All of their programs are on hold now.

Halozyme has been in contact with the Center for Drug Evaluation and Research (CDER) regarding the impact on Hylenex® recombinant (hyaluronidase human injection). CDER is the division of FDA regulating the other investigational rHuPH20 programs, including insulin and PEGPH20. After reviewing the data, CDER has confirmed that there is no need for actions against Hylenex or clinical programs in the Hylenex IND.

http://finance.yahoo.com/news/halozyme-confirms-baxter-received-complete-200500804.html